Home / Japan / SymBio Pharmaceuticals Limited
SymBio Pharmaceuticals Limited
Short position disclosed on September 18, 2026.
3.88% of the capital sold short
3 disclosing funds
41 disclosures on record
Evolution of the disclosed total
0%2%4%6%
Aug 13Aug 23Sep 2Sep 12Sep 22
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Nomura International plc | 2.13% | new | September 17, 2026 | |
| モルガン・スタンレーmufg証券株式会社 | 0.89% | new | September 18, 2026 | |
| JPM Securities Japan Co Ltd. | 0.86% | -0.39 pt | September 17, 2026 |
Get the moves on SymBio Pharmaceuticals Limited by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 41 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- Metaplanet Inc. 12.12% of the capital sold short
- Towa Corporation 10.64% of the capital sold short
- 3-D Matrix,Ltd. 10.34% of the capital sold short
- KLab Inc. 10.28% of the capital sold short
- QD Laser,Inc. 10.26% of the capital sold short
- Jibannet Holdings Co.,Ltd. 9.53% of the capital sold short
- SHIFT Inc. 9.38% of the capital sold short
- ReYuu Japan Inc. 8.91% of the capital sold short
- Renascience Inc. 8.76% of the capital sold short
- Unitika LTD. 8.57% of the capital sold short
- Fixstars Corporation 7.96% of the capital sold short
- Infomart Corporation 7.44% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, SymBio Pharmaceuticals Limited, source JPX, data as at September 18, 2026, https://www.quivad.com/action/symbio-pharmaceuticals-limited